Prevalence of hypertension in Europe & Central Asia (IDA & IBRD countries)

Europe & Central Asia (IDA & IBRD countries): Prevalence of hypertension was 43.1% in 2019. ▼ Falling

Latest (2019)
43.1%
Change on year
down 0.5%
Rank
2nd
of 43 groups
All-time high
48.4%
in 1990
All-time low
43.1%
in 2019
Years of data
30
1990–2019

Prevalence of hypertension in Europe & Central Asia (IDA & IBRD countries), 1990–2019

010203040501990200420191990: 48.4 % of adults ages 30-791991: 48.1 % of adults ages 30-791992: 47.9 % of adults ages 30-791993: 47.7 % of adults ages 30-791994: 47.5 % of adults ages 30-791995: 47.3 % of adults ages 30-791996: 47.1 % of adults ages 30-791997: 46.9 % of adults ages 30-791998: 46.7 % of adults ages 30-791999: 46.6 % of adults ages 30-792000: 46.4 % of adults ages 30-792001: 46.3 % of adults ages 30-792002: 46.2 % of adults ages 30-792003: 46.1 % of adults ages 30-792004: 46 % of adults ages 30-792005: 45.9 % of adults ages 30-792006: 45.7 % of adults ages 30-792007: 45.6 % of adults ages 30-792008: 45.5 % of adults ages 30-792009: 45.3 % of adults ages 30-792010: 45.1 % of adults ages 30-792011: 44.9 % of adults ages 30-792012: 44.7 % of adults ages 30-792013: 44.5 % of adults ages 30-792014: 44.2 % of adults ages 30-792015: 44 % of adults ages 30-792016: 43.8 % of adults ages 30-792017: 43.5 % of adults ages 30-792018: 43.3 % of adults ages 30-792019: 43.1 % of adults ages 30-79

Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of adults ages 30-79.

Analysis

The most recent figure for prevalence of hypertension in Europe & Central Asia (IDA & IBRD countries) is 43.1%, measured in 2019. That is the lowest value across all 30 years on record.

Compared with earlier readings it is down 0.5% on the previous year and down 4.9% over ten years.

Over the whole period, prevalence of hypertension in Europe & Central Asia (IDA & IBRD countries) peaked at 48.4% in 1990 and was at its lowest, 43.1%, in 2019.

Europe & Central Asia (IDA & IBRD countries) ranks 2nd of 43 groups on this measure, in the top 10%.

The long-run direction has been consistently falling across the 30 years of available data.

Prevalence of hypertension in Europe & Central Asia (IDA & IBRD countries), year by year

Annual values for Prevalence of hypertension (% of adults ages 30-79) in Europe & Central Asia (IDA & IBRD countries), 1990 to 2019.
Year % of adults ages 30-79 Change
1990 48.4%
1991 48.1% -0.5%
1992 47.9% -0.4%
1993 47.7% -0.4%
1994 47.5% -0.5%
1995 47.3% -0.4%
1996 47.1% -0.5%
1997 46.9% -0.4%
1998 46.7% -0.4%
1999 46.6% -0.3%
2000 46.4% -0.3%
2001 46.3% -0.2%
2002 46.2% -0.2%
2003 46.1% -0.3%
2004 46.0% -0.2%
2005 45.9% -0.3%
2006 45.7% -0.3%
2007 45.6% -0.3%
2008 45.5% -0.4%
2009 45.3% -0.4%
2010 45.1% -0.3%
2011 44.9% -0.5%
2012 44.7% -0.5%
2013 44.5% -0.5%
2014 44.2% -0.5%
2015 44.0% -0.5%
2016 43.8% -0.5%
2017 43.5% -0.6%
2018 43.3% -0.5%
2019 43.1% -0.5%

Averages by decade

DecadeAverage LowestHighest Years
1990s 47.4% 46.6% 48.4% 10
2000s 45.9% 45.3% 46.4% 10
2010s 44.1% 43.1% 45.1% 10

Countries ranked near Europe & Central Asia (IDA & IBRD countries)

  1. 1 Paraguay 56.4% compare
  2. 2 Tuvalu 50.4% compare
  3. 3 Belarus 49.2% compare
  4. 3 Poland 49.2% compare
  5. 5 Dominican Republic 49.1% compare

See the full ranking of 235 places →

More health data for Europe & Central Asia (IDA & IBRD countries)

All data for Europe & Central Asia (IDA & IBRD countries) →

Frequently asked questions

What is prevalence of hypertension in Europe & Central Asia (IDA & IBRD countries)?
Prevalence of hypertension in Europe & Central Asia (IDA & IBRD countries) was 43.1% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
What is the highest prevalence of hypertension recorded in Europe & Central Asia (IDA & IBRD countries)?
The highest recorded value was 48.4% in 1990.
What is the lowest prevalence of hypertension recorded in Europe & Central Asia (IDA & IBRD countries)?
The lowest recorded value was 43.1% in 2019.
How does Europe & Central Asia (IDA & IBRD countries) rank for prevalence of hypertension?
Europe & Central Asia (IDA & IBRD countries) ranks 2nd out of 43 groups with data for 2019.
Is prevalence of hypertension rising or falling in Europe & Central Asia (IDA & IBRD countries)?
Over the last ten years it is down 4.9%. The long-run trend across the full record is falling.
Where does this Europe & Central Asia (IDA & IBRD countries) data come from?
The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Prevalence of hypertension (% of adults ages 30-79). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Prevalence of hypertension in Europe & Central Asia (IDA & IBRD countries). Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 18 September 2026, from https://health.statizoid.com/stat/prevalence-of-hypertension-percent-of-adults-ages-30-79/europe-and-central-asia-ida-and-ibrd-countries/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/prevalence-of-hypertension-percent-of-adults-ages-30-79/europe-and-central-asia-ida-and-ibrd-countries/">Prevalence of hypertension in Europe & Central Asia (IDA & IBRD countries)</a> — Statizoid

About this data

Indicator
Prevalence of hypertension (% of adults ages 30-79)
Unit
% of adults ages 30-79
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Prevalence of hypertension is the percentage of adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.